.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075687

« Back to Dashboard
NDA 075687 describes CARBAMAZEPINE, which is a drug marketed by Usl Pharma, Taro, Torrent Pharms, Wockhardt, Warner Chilcott, Inwood Labs, Jubilant Cadista, Apotex Inc, Pliva, Taro Pharm Inds, Teva Pharms, Actavis Elizabeth, and Mylan Ireland Ltd, and is included in eighteen NDAs. It is available from thirty suppliers. Additional details are available on the CARBAMAZEPINE profile page.

The generic ingredient in CARBAMAZEPINE is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-four suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the carbamazepine profile page.

Suppliers and Packaging for NDA: 075687

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARBAMAZEPINE
carbamazepine
TABLET, CHEWABLE;ORAL 075687 ANDA REMEDYREPACK INC. 24236-025 24236-025-02 30 TABLET, CHEWABLE in 1 BLISTER PACK (24236-025-02)
CARBAMAZEPINE
carbamazepine
TABLET, CHEWABLE;ORAL 075687 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4041 51672-4041-0 10 BLISTER PACK in 1 CARTON (51672-4041-0) > 10 TABLET, CHEWABLE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength100MG
Approval Date:Oct 24, 2000TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength200MG
Approval Date:Jul 29, 2002TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc